Bernstein Liebhard LLP Investigates Claims on Behalf of Shareholders of Teva Pharmaceuticals Industries, Ltd.
Feb. 8, 2017
Bernstein Liebhard LLP is investigating whether the Board of Directors of Teva Pharmaceuticals Industries, Ltd. (“Teva” or the “Company”) (NYSE: TEVA) breached their fiduciary duties to the Company’s shareholders.
On February 7, 2017, amid reports of a bribery investigation, Teva announced that its Chief Executive Officer Erez Vigodman will resign. Teva shares fell approximately 6% on this adverse news.
Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3.5 billion for its clients. The Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times.